Sign In
Buy NBY
$1.47
+0 (+0%)
At Close: Jun 08, 2026
Mid-Afternoon Market Update: Qudian Falls Following Downbeat Q3 Earnings; NovaBay Pharmaceuticals Shares Jump
12:00am, Monday, 18'th Nov 2019NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q3 2019 Results - Earnings Call Transcript
12:00am, Sunday, 10'th Nov 2019NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results
09:05pm, Thursday, 07'th Nov 2019
Conference call begins at 4:30 p.m. Eastern time today
NovaBay Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 sales results.
12:00am, Thursday, 07'th Nov 2019
CelleRx is a skin and wound cleanser based on NovaBay’s proprietary pure hypochlorous formulation, and is proven to gently clean and ease discomfort following aesthetic dermatology and cosmetic surg
NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019
10:50am, Thursday, 31'st Oct 2019
NovaBay® Pharmaceuticals, Inc. , a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that it will report third quarter 2019 financial results
NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies
10:50am, Monday, 28'th Oct 2019
The NuLids System is a hand-held, cordless device that safely and effectively removes accumulated scurf from eyelashes and eyelids, while stimulating meibomian gland production in dry eye and blephari
Market Morning: Prorogation Ruled Rogue, High Demand for Fed Repo, New Breast Cancer Tests
06:20pm, Tuesday, 24'th Sep 2019
British High Court Rules Against Johnson Parliament Prorogation Apparently, proroguing Parliament was not Boris Johnson’s prerogative. The British high court ruled today that the Prime Minister acte
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia
10:50am, Tuesday, 24'th Sep 2019
“We are pleased to receive approval to market Avenova in Australia and are planning to engage a distributor in the near term,” said Justin Hall, NovaBay president and CEO. “This marks another s
